Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?
- PMID: 27536439
- PMCID: PMC4937652
- DOI: 10.3109/21556660.2013.801605
Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?
Keywords: Anti-hypertensive; Anti-platelet drugs; Hypoglycemic; Hypolipidemic; Single-pill combinations; Vascular risk.
References
-
- Pfeiffer D, Rennie N, Papst CC, Zhang J. Efficacy and tolerability of aliskiren/amlodipine single-pill combinations in patients who did not respond fully to amlodipine monotherapy. Curr Vasc Pharmacol 2012;10:773-80 - PubMed
-
- Glorioso N Thomas M Troffa C et al. Antihypertensive efficacy and tolerability of aliskiren/amlodipine single-pill combinations in patients with an inadequate response to aliskiren monotherapy. Curr Vasc Pharmacol 2012;10:748-55 - PubMed
-
- Katsiki N Athyros VG Mikhailidis DP et al. Editorial: aliskiren/amlodipine single-pill combinations: more evidence in favour of combination formulations for the treatment of hypertension. Curr Vasc Pharmacol 2012;10:745-7 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources